Ayako Suzuki

16.8k citations
196 papers · 10.1k · 6 hit papers · h-index 45

Impact in

  • Hepatology top 0.5%
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
    • Liver physiology and pathology
  • Pharmacology top 0.1%
    • Drug-Induced Hepatotoxicity and Protection
    • Pharmacogenetics and Drug Metabolism

Papers in

    • Liver Disease Diagnosis and Treatment 51
    • Drug-Induced Hepatotoxicity and Protection 27
    • Pharmacogenetics and Drug Metabolism 9

Ayako Suzuki

184 papers receiving 9.9k citations

Ayako Suzuki's Hit Papers

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury 2022 · 131 citations
1310+5+10Years since publication4008001.2k

Peers

Ayako Suzuki
Comparison fields: 5 of 191
  • Hepatology 1.6k
  • Pharmacology 1.3k
  • Epidemiology 4.2k
  • Endocrinology, Diabetes and Metabolism 1.8k
  • Pathology and Forensic Medicine 688
Replace Wanqing Chen with:
Wanqing Chen China
Hongmei Zeng China
Katherine A. McGlynn United States
Sultan Eser Türkiye
Jiemin Ma United States
Robert Makuch United States
Marise Souto Rebelo Brazil
Simon D. Taylor‐Robinson United Kingdom
S. Jane Henley United States
Peter D. Baade Australia
Ayako Suzuki relative to Wanqing Chen China Wanqing Chen's profile →
Citations per field
00.5×4.8×
Wanqing Chen · 1×
Citations per year

Countries citing papers authored by Ayako Suzuki

Since Specialization
Citations

This map shows the geographic impact of Ayako Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Suzuki more than expected).

Fields of papers citing papers by Ayako Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Suzuki. The network helps show where Ayako Suzuki may publish in the future.

Co-authors

The 25 scholars most cited alongside Ayako Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ayako Suzuki Line = papers co-authored together Ayako Suzuki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sex and gender: modifiers of health, disease, and medicine
Hit paper breakdown →
20201230
2
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
Hit paper breakdown →
2019723
3
Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver Disease
Hit paper breakdown →
2010590
4
Drug-induced liver injury
Hit paper breakdown →
2019570
5 2008387
6 2013304
7 2015296
8
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
Hit paper breakdown →
2016279
9 2013277
10 2005257
11 2014253
12 2013235
13 2011234
14 2005176
15 2011169
16 2016156
17 2011146
18 2010143
19 2007142
20 2004142

About Ayako Suzuki

Ayako Suzuki is a scholar working on Epidemiology, Pharmacology, Endocrinology, Diabetes and Metabolism, Hepatology and Surgery, having authored 196 papers that have together received 10.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (51 papers), Drug-Induced Hepatotoxicity and Protection (27 papers), Diet, Metabolism, and Disease (18 papers), Liver Disease and Transplantation (11 papers), Pharmacogenetics and Drug Metabolism (9 papers), Liver Diseases and Immunity (7 papers), Pancreatitis Pathology and Treatment (6 papers) and COVID-19 epidemiological studies (5 papers). The work is most often cited by research in Hepatology (1.6k citations), Pharmacology (1.3k citations), Epidemiology (4.2k citations), Endocrinology, Diabetes and Metabolism (1.8k citations) and Pathology and Forensic Medicine (688 citations). Ayako Suzuki has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Manal F. Abdelmalek, Anna Mae Diehl, Cynthia D. Guy, Amedeo Lonardo, Keith D. Lindor, Raúl J. Andrade, M. Isabel Lucena, Paul Angulo, Minjun Chen and Aynur Ünalp–Arida. Their work appears in journals such as Hepatology, Gastroenterology, Clinical Gastroenterology and Hepatology, Liver International and International Journal of Environmental Research and Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact